Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects

por Li, Yinhua, Mu, Yuting, Shi, Haihong, Liang, Yali, Liu, Zeyuan, Matschke, Kyle, Hickman, Anne, Krishna, Rajesh, Sahasrabudhe, Vaishali
Publicado 2019

Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia

por Ji, Linong, Liu, Yanmei, Miao, Heng, Xie, Yongli, Yang, Ming, Wang, Wei, Mu, Yuting, Yan, Ping, Pan, Sharon, Lauring, Brett, Liu, Shu, Huyck, Susan, Qiu, Yanping, Terra, Steven G.
Publicado 2019